Evidence

Better diabetes
management,
evidence-based.

Published, peer-reviewed clinical studies show
Glooko improves patient outcomes.

SUSTAINED REDUCTION IN HbA1c WITH
GLOOKO RPM (REMOTE PATIENT MONITORING)
FOR TYPE 2 PATIENTS.

Glooko maintained reduction in hbA1c at 3 and 6 months.

*Data on file

Sustained glycemic improvements with
Glooko RPM (Remote Patient Monitoring).

Improvement in key metrics at 3, 6, 12 months.

*Data on file

Use of the Glooko mobile app
improves glycemic outcomes.

Glooko maintained reduction in hbA1c at 3 and 6 months.

  • Drops in average blood glucose and hperglycemia in 2 months.
  • Use of Glooko mobile app features (food logging and reminders) also improves the above.

*Data on file

After stopping Glooko use,
patient outcomes decline in 6-8 weeks.

+5

Mg/dL
Average increase
in blood glucose.

-1.7%

In-range
reading

+3%

hyperglycemia

*Data on file